Telesis Bio Inc expected to post a loss of 22 cents a share - Earnings Preview

Telesis Bio

15/03/2024 20:16

* Telesis Bio Inc  TBIO.OQ   TBIO.O  is expected to show a
fall in
quarterly revenue when it reports  results on March 19
(estimated) for the period ending December 31 2023
    * The San Diego California-based  company is expected to
report a
26.1% decrease in revenue to $7 million from $9.47 million a
year ago, according to the estimate from one analyst, based on
LSEG data.
    * ​LSEG's mean analyst estimate for Telesis Bio Inc is for a
loss
of 22 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Telesis Bio
Inc
is $4.00​, above​ its last closing price of $0.51. ​​​

This summary was machine generated March 15 at 20:16 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)